Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$63.2M
-5.6% from 2023
Prescriptions
517K
$122.44 per claim
Patients
116K
51,417 prescribers
Total spending, 2024
$63.3M
$544.71 per patient
Medicare prescription drug plans paid $63.2M for Mycophenolate Mofetil in 2024, for 516,525 prescriptions and refills to 116,090 patients (down 5.6% from 2023). The average cost per claim was $122.44.
California had the highest Medicare cost for Mycophenolate Mofetil in 2024: $6.8M for 51,082 claims, followed by New York ($5.0M).
Debabrata Bandyopadhyay, pulmonary disease in Orlando, FL, had the highest Medicare cost for Mycophenolate Mofetil in 2024: 203 claims costing $90K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Debabrata Bandyopadhyay Orlando, FL | Pulmonary Disease | 203 | 48 | $90K |
| Rajiv E Shah Winston Salem, NC | Ophthalmology | 593 | 166 | $82K |
| Elvin R Garcia |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 46,175 | 439,114 | 99,033 | $64.3M |
| 2023 | 48,472 | 468,833 | 105,453 | $67.0M |
| 2024 | 51,417 | 516,525 | 116,090 | $63.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Rheumatology |
| 366 |
| 103 |
| $66K |
| Abie A Samuel St Petersburg, FL | Rheumatology | 57 | 13 | $63K |
| Bernard S Hojaili New Iberia, LA | Internal Medicine | 474 | 93 | $56K |
| Michael T Pulley Jacksonville, FL | Neurology | 153 | 28 | $50K |
| Leonard Lobo Chapel Hill, NC | Pulmonary Disease | 347 | 96 | $50K |
| Michelle Kittleson Beverly Hills, CA | Cardiology | 379 | 111 | $49K |
| Jessica Chapman Queensbury, NY | Rheumatology | 99 | 35 | $49K |
| Gopisree Peringeth Bronx, NY | Student in an Organized Health Care Education/Training Program | 43 | Under 11 | $46K |
| Todd B Dunaway Tulsa, OK | Neurology | 264 | 56 | $46K |
| Flavia V Castelino Boston, MA | Rheumatology | 86 | 22 | $46K |
| Lisa K Pappas-Taffer Philadelphia, PA | Dermatology | 72 | 20 | $46K |
| Deepak Venkat Detroit, MI | Gastroenterology | 439 | 128 | $45K |
| Shawn J Bird Philadelphia, PA | Neurology | 191 | 37 | $44K |
| Alberto S Santos-Ocampo Honolulu, HI | Rheumatology | 51 | 12 | $43K |
| Chadwick R Johr Philadelphia, PA | Rheumatology | 80 | 14 | $42K |
| Steven J Cohen Tyler, TX | Rheumatology | 389 | 83 | $41K |
| Supraja Yeturi Opelousas, LA | Internal Medicine | 166 | 29 | $41K |
| Yih Chang C Lin Tampa, FL | Rheumatology | 97 | 29 | $40K |
| Adam D Devore Durham, NC | Advanced Heart Failure and Transplant Cardiology | 396 | 87 | $39K |
| Adam J Kreitenberg Tarzana, CA | Rheumatology | 53 | 13 | $38K |
| Rafael Khaim New York, NY | Nurse Practitioner | 316 | 114 | $38K |
| Steffan W Schulz Philadelphia, PA | Rheumatology | 96 | 26 | $38K |
| Gerald Y Ho La Palma, CA | Rheumatology | 303 | 69 | $38K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Strides Pharma STAR.NS | 216,716 | $23.9M |
| Ascend Laborato ALKEM.NS | 79,160 | $11.8M |
| Sandoz SDZ.SW | 61,010 | $6.5M |
| Avet Pharmaceut | 37,012 | $5.7M |
| Accord Healthca | 42,042 | $3.8M |
| Advagen Pharma | 29,672 | $3.3M |
| Vistapharm/Pai | 3,139 | $3.0M |
| Teva USA TEVA | 32,295 | $2.6M |
| Roxane/West-War | 9,874 | $1.0M |
| Lannett Co. Inc | 877 | $820K |
| Amneal Pharmace AMRX | 1,121 | $368K |
| Aurobindo Pharm AUROPHARMA.NS | 3,211 | $320K |
| Mylan VTRS | 325 | $33K |
| Lupin Pharmaceu LUPIN.NS | 131 | $10K |
| Mylan Instituti VTRS | 74 | $3,182 |
| Major Pharmaceu | 38 | $1,228 |